In the synthesis of structurally complex small-molecule antiviral agents, the thiazole ring constitutes a non-negotiable pharmacophore for metal-chelating integrase strand transfer inhibitors (INSTIs). 2-(Tert-Butoxycarbonylamino)thiazole-5-carboxylic acid serves as a fully protected, crystalline precursor that eliminates the need for in situ amino protection during late-stage amide bond formation with secondary amine-bearing polycyclic cores. On a pilot-plant scale, coupling reactions typically deploy 1.05–1.15 molar equivalents of the acid relative to the amine substrate, activated via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and 1-hydroxybenzotriazole (HOBt) in anhydrous N,N-dimethylformamide (DMF) at 0–5 °C to suppress racemization of adjacent chiral centers. Process analytical technology (PAT) integration using ReactIR monitors the disappearance of the carbonyl stretch at ∼1690 cm⁻¹, enabling endpoint determination within ±2% conversion. Isolation via pH-adjusted crystallization from 2-propanol/water (7:3 v/v) consistently yields > 99.5% purity as measured by HPLC (area normalization, UV detection at 254 nm) with individual unspecified impurities capped at ≤0.10%. Compliance with ICH Q7A for GMP intermediate production mandates heavy metal limits per USP <231> (class 2 elements: Pd ≤10 µg/g, Ni ≤20 µg/g) and residual solvent thresholds per USP <467> (DMF ≤880 ppm, 2-propanol ≤5000 ppm). The deprotected free amine is immediately telescoped into the next oxadiazole-forming step without storage, as exposure to ambient moisture prompts hydrate formation on the thiazole C-4 position, altering reactivity kinetics. The terminal active pharmaceutical ingredient (API) obtained through this route exhibits particle size distribution D90 < 30 µm after jet milling, suited for direct compression tablet formulations at 400 mg dose strength.
The direct incorporation of Boc-2-aminothiazole-5-carboxylic acid into resin-bound peptide chains introduces a heteroaryl turn-inducing residue that has been exploited in macrocyclic peptidomimetics targeting protein–protein interfaces. Coupling efficiency on 2-chlorotrityl chloride resin (loading 0.8–1.2 mmol/g) is critically dependent on the activation cocktail composition: PyBOP (3.0 eq) with 1-hydroxy-7-azabenzotriazole (HOAt, 3.0 eq) and N-methylmorpholine (NMM, 6.0 eq) in N-methyl-2-pyrrolidone (NMP) at 40 °C for 45 minutes achieves stepwise coupling yields above 98.5% as quantified by Fmoc release spectrophotometric monitoring at 301 nm. Lowering the temperature to 25 °C results in a 12–15% drop in efficiency due to the steric hindrance imposed by the syn-orientation of the Boc-carbamate oxygen to the thiazole C-2 nitrogen. During TFA-mediated global deprotection (TFA/TIS/H₂O 95:2.5:2.5), premature cleavage of the Boc group occurs within 8–10 minutes, exposing a free amine that is susceptible to thiazole ring modification by triethylsilane carbocations unless thioanisole (5% v/v) is added as a scavenger. The downstream production stream encompasses preparative RP-HPLC purification on a C18 column (250 × 50 mm, 10 µm particle size) with a linear gradient from 15% to 55% acetonitrile (0.1% TFA) over 40 minutes at a flow rate of 60 mL/min. The target peptide drug candidate produced via this solid-phase route must meet the specification for bacterial endotoxins as per USP <85> (≤0.5 EU/mg) when destined for parenteral administration as a lyophilized powder. Residual palladium analysis by ICP-MS is enforced as per ICH Q3D if any fragment synthesis involves Pd-catalyzed cross-coupling, with a permitted daily exposure limit of ≤100 µg/day for oral products.
Fragment-based lead discovery targeting the hinge region of Bruton’s tyrosine kinase (BTK) and interleukin-2-inducible T-cell kinase (ITK) has validated 2-aminothiazole-5-carboxylic acid as a privileged fragment. Screening libraries derived from this scaffold require Boc-protection at the C-2 exocyclic nitrogen to prevent non-specific interactions with aspartate-rich ATP-binding pockets during initial hit identification. The fragment is elaborated in solution phase: a typical growth vector involves amidation using Boc-amino-thiazole carboxylic acid (1.0 eq) with substituted anilines promoted by propylphosphonic anhydride (T3P, 50% in EtOAc, 1.6 eq) and pyridine (2.0 eq) in ethyl acetate at 20–23 °C for 16 hours. This protocol was specifically selected to avoid the formation of a persistent N-acylurea byproduct that co-elutes with the target compound on silica gel flash chromatography (230–400 mesh, eluent: hexane/ethyl acetate 1:3 to ethyl acetate/methanol 9:1). Quality control of the Boc-protected intermediate for kinase profiling relies on a combination of quantitative ¹H NMR (using 1,3,5-trimethoxybenzene as an internal standard, accuracy ±1.0% w/w) and LC-MS electrospray ionization in positive mode (ESI+), with trace analysis for potential genotoxic impurities as described in the ICH M7(R2) guideline. Specifically, the mesylate and besylate esters of hydroxybenzotriazole are screened at a TTC-based acceptable intake of ≤1.5 µg/day for a treatment duration exceeding 10 years. The resulting kinase inhibitor candidate is formulated as an amorphous solid dispersion using hot-melt extrusion with copovidone (Kollidon VA 64) at a drug load of 30% w/w, extruded through a 16 mm twin-screw extruder at a barrel temperature profile of 150 °C to 170 °C and screw speed 300 rpm, achieving enhanced bioavailability in preclinical species.
Photoaffinity Labeling Reagents: Probe Assembly and Crosslinking Validation
Chemical proteomics workflows that map cellular targets of bioactive thiazole-containing ligands often demand bi-functional probes where the Boc-amino-thiazole carboxylic acid moiety acts as the recognition element. The synthesis of trifunctional diazirine-based probes commences with the activation of the acid as an N-hydroxysuccinimidyl (NHS) ester: Boc-amino-thiazole-5-carboxylic acid is treated with TSTU (O-(N-succinimidyl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate, 1.05 eq) and DIPEA (2.2 eq) in anhydrous acetonitrile at 0 °C for 2 hours, followed by precipitation from cold diethyl ether to obtain the active ester as a moisture-sensitive white powder. This intermediate is immediately reacted with a bifunctional PEG₃-diamine linker in a 1:1.5 molar ratio to install a primary amine, which is then acylated with an NHS-diazirine succinimidyl ester to construct the complete photocrosslinking probe. The manufacturing process is conducted under amber light conditions and requires strict enforcement of USP <1050> (ICH Q1B Option 2) for photostability of the diazirine moiety. Purification is achieved through preparative reverse-phase flash chromatography on a C18 column with a gradient of 5–95% methanol in water, the product eluting at approximately 65% methanol. The final probe is characterized by high-resolution mass spectrometry (HRMS-ESI, resolution >30,000 FWHM) and must demonstrate >95% UV-dependent crosslinking efficiency with bovine serum albumin as a model substrate when irradiated at 365 nm for 15 minutes at a total energy dose of 4.5 J/cm², as quantified by SDS-PAGE with Coomassie staining and in-gel fluorescence. Published data for this specific diazirine-PEG₃-thiazole configuration regarding cell permeability in HeLa cells indicates a logD₇.₄ of 0.28 ± 0.05, suggesting moderate membrane transit capability.
| Test Parameter | Method/Standard | Acceptance Limit | Instrument Configuration |
|---|---|---|---|
| Residual DMF | USP <467> (Method IV) | ≤880 ppm | GC-FID, DB-624 column 30 m × 0.32 mm, 1.8 µm film |
| Residual 2-Propanol | USP <467> (Method IV) | ≤5000 ppm | GC-FID, as above, headspace injection 85 °C |
| Palladium (Pd) | USP <233> (ICP-MS) | ≤10 µg/g | ICP-MS, plasma power 1550 W, m/z 105 |
| Nickel (Ni) | USP <233> (ICP-MS) | ≤20 µg/g | ICP-MS, m/z 60, collision cell mode with He |
| Copper (Cu) | ICH Q3D (Class 2A) | ≤300 µg/g | ICP-OES, Cu 324.754 nm line |
| Bacterial Endotoxins | USP <85> (Gel Clot) | < 0.15 EU/mg | Assay at sensitivity 0.06 EU/mL |
What Processing Constraints Arise When Scaling Boc-Deprotection in Continuous Flow for Thiazole Acid Derivatives?
Adoption of continuous-flow processing for the acidic Boc removal step in the synthesis of the unprotected 2-aminothiazole-5-carboxylic acid addresses the exothermicity hazard intrinsic to batch-mode HCl/dioxane deprotection. In a Corning Advanced-Flow reactor (plate-type, volume 0.45 mL per plate, 8 plates connected in series), a 0.25 M solution of Boc-amino-thiazole-5-carboxylic acid in anhydrous 1,4-dioxane is combined with 4.0 M HCl in 1,4-dioxane (1:3 v/v at a total flow rate of 1.2 mL/min, residence time 2.4 min) at a set temperature of 55 °C and a system back-pressure of 7 bar to maintain single-phase operation and prevent bubble nucleation in the microchannels. Immediate quenching of the effluent into pre-cooled (−10 °C) methyl tert-butyl ether induces precipitation of the hydrochloride salt with consistent batch-to-batch particle morphology (platelet-shaped crystals, D50 8–12 µm) that filters efficiently on a sintered Nutsche filter under nitrogen pressure. The temperature window is narrow: deviations exceeding +5 °C provoke partial decarboxylation of the thiazole ring at the 5-position, detected as a 1.5–2.1% area impurity by UPLC (1290 Infinity, C18 2.1 × 50 mm, 1.7 µm). The decarboxylated byproduct (2-aminothiazole hydrochloride) elutes with a relative retention time of 0.63 and must be controlled to ≤0.15% to meet the impurity specification for a key starting material in an ANDA submission. Equipment qualification follows ASTM E2500-20 for risk-based verification, and the continuous-flow system’s process analytical control loop employs an inline FTIR probe (KBr beamsplitter, DTGS detector) tracking the C=O vibration shift from 1705 cm⁻¹ (Boc carbamate) to 1740 cm⁻¹ (carboxylic acid protonated), with a data acquisition frequency of 1 spectrum/second. The final product after drying in a vacuum oven at 40 °C / 5 mbar for 8 hours demonstrates a water content by Karl Fischer (method Ia per USP <921>) ≤0.5%, critical for downstream anhydrous coupling steps.
| Coupling Reagent | Resin Type | Crude Purity (HPLC, 214 nm) | Racemization (L-isomer % via Marfey's) | Cost Index per mmol |
|---|---|---|---|---|
| PyBOP / HOAt / NMM | 2-CTC resin | 94.6% | 0.8 ± 0.15% D-isomer | 1.00 |
| HATU / DIPEA | 2-CTC resin | 91.2% | 1.2 ± 0.20% D-isomer | 0.85 |
| COMU / Oxyma / DIPEA | Wang resin | 89.8% | 2.5 ± 0.30% D-isomer | 1.15 |
The utilization of Boc-2-aminothiazole-5-carboxylic acid as a capping agent in degradable polymer synthesis has been explored for polyester-based drug-eluting coronary stents. In a ring-opening polymerization of d,l-lactide and glycolide (85:15 molar ratio) catalyzed by tin(II) 2-ethylhexanoate (Sn(Oct)₂, 0.05 mol% relative to monomer) at 140 °C under nitrogen blanket, the thiazole acid is introduced as a mono-functional initiator at a ratio of 1:250 (initiator:total monomer) to generate a polymer with a terminal carboxylic acid. After 48 hours, the molecular weight determined by GPC-MALS (dn/dc 0.043 mL/g in THF) plateaus at 18–22 kg/mol, with a Đ 1.18–1.22. The Boc group remains intact during the melt polymerization, as confirmed by FTIR analysis of the polymer film (retention of the carbamate C=O stretch at 1685 cm⁻¹). Subsequent deprotection with TFA vapor in a vacuum chamber at 40 °C for 60 minutes liberates the surface amino groups, which are immediately conjugated with a phosphonylcholine derivative under Schotten-Baumann conditions to create a hemocompatible coating. Compliance with ISO 10993-4 for blood-contacting devices necessitates a hemolysis index < 2% and platelet adhesion count below 5 per 1000 µm² on scanning electron microscopy after 30-minute incubation with platelet-rich plasma. The fully formulated coated stent prototype exhibited a sirolimus elution profile of 80% cumulative release within 28 days as per a USP Apparatus 4 flow-through method (Sotax CE7, flow rate 12 mL/min, PBS pH 7.4 with 0.5% SDS). Published quantitative structure-property relationship data are limited for this precise polymer-thiazole matrix, but accelerated stability testing at 40 °C/75% RH for 3 months showed no significant hydrolysis of the ester backbone as assessed by GPC peak retention time shifts.
